January 18, 2023

FDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools

Cytovale announced today that its IntelliSep® test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present to US emergency departments (ED) each year.

Read More


Additional Publications


Additional Resources

Small Scientific Journal

Focusing Cells to Single Streams

Read More
Microsystems & Nanoengineering

Biophysical Classification of Cell Differentiation State

Read More
Nature - Scientific Reports

Introducing the Cell Mechanome

Read More
Annual Review of Biomedical Engineering

New Opportunities for Rapid Mechanical Measurement of Cells

Read More
Current Opinion in Biotechnology

Advances in high-throughput single-cell microtechnologies

Read More
Do you have an application for our technology?

Contact Us